Kimberly Manhard Heron Therapeutics, Inc. (HRTX) insider trading activity

Kimberly Manhard is EVP, Drug Development of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 28,330 shares of HRTX, which is worth approximately $49,294. The most recent transaction as insider was on Dec 22, 2020, when has been sold 10,000 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $200,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.3K

0% 3M change

0% 12M change

Total Value Held $49,294

KIMBERLY MANHARD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Dec 22 2020	SELL Open market or private sale	$200,000 $20.0 p/Share	10,000 Reduced 100.0%	0 Common Stock
Dec 22 2020	BUY Exercise of conversion of derivative security	$130,000 $13.0 p/Share	10,000 Added 50.0%	10,000 Common Stock

Also insider at

INBX

Inhibrx, Inc. Healthcare

Director

INXB

Inhibrx Biosciences, Inc.

Director